ESG
How a healthcare partnership is steering environmental impact beyond plastics
On World Environment Day 2025, the theme Beat Plastic Pollution lands with particular weight in the healthcare sector – an industry long reliant on plastics for safety, sterility and logistics. But as the sector continues to confront its environmental footprint, what does action beyond intention really look like?
In this Health Industry Hub podcast, Omar Sarwary, Customer Care and Order Operations Director at Medtronic ANZ, and George Boutros, Chief Operating Officer at Hoxton Industries, join the conversation to explore the realities of making sustainability practical.
Sarwary speaks to the widening gap between ambition and execution, where bold national plans like Australia’s National Health and Climate Strategy are too often stalled by slow-moving policy, overlapping jurisdictions, and a system still hesitant to move beyond pilot mode.
The duo unpack the Medtronic-Hoxton Industries* partnership, a compelling example of what happens when a global medtech company collaborates with a local social enterprise to shift environmental sustainability from talk to traction, creating meaningful impact for both people and the planet.
*Hoxton Industries provides meaningful employment to more than 100 people who face barriers to mainstream employment, including people living with disabilities.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics

Philips remote monitoring cuts hospital costs and ICU time by 69%
An innovative remote patient monitoring model has significantly improved post-operative care for patients, cutting ICU hours by 69% and saving […]
MoreNews - MedTech & Diagnostics

VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business
VB Spine has officially taken the reins of Stryker’s spinal implants business in Australia and New Zealand. The transition builds […]
MoreNews - Pharmaceuticals

New therapy PBS listed in advanced Parkinson’s disease
A new therapeutic option for advanced Parkinson’s disease, Vyalev (foslevodopa with foscarbidopa), is now listed on the Pharmaceutical Benefits Scheme […]
MoreNews - Pharmaceuticals

PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions
From 1 August 2025, two new biosimilars – SteQeyma (ustekinumab) and Omlyclo (omalizumab) – have been listed on the Pharmaceutical […]
More